Colitis clinical trials in Illinois
3 studies for Colitis are looking for participants at sites in Illinois.
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-005, Des Plaines
- Site US-007, Glenview
- Site US-020, Gurnee
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07845487A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 038, Chicago
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07012395Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
- Northwestern University, Chicago
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated May 22, 2026 · NCT07427017From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.